InterventionsHuman trial116 participants72 weeksRandomised trialDouble-blindPlacebo-controlledMulticentreRegistered NCT04822181

Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial

Journal of Gastroenterology

The paper

Atsushi Nakajima, Takeshi Okanoue, Yoichi Hiasa,

Hirokazu Takahashi, Kwabena Opuni, Nobuyoshi Kosaka, Tomoyuki Nishida,

Arun Jayant Sanyal

International University Of Health And Welfare Atami Hospital · Virginia Commonwealth University

Journal of Gastroenterology · 28 Aug 2026

doi.org/10.1007/s00535-026-02507-0 PubMed 42663669

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Three-protein combination eased chronic liver disease in rats
Communications Biology · 6 Oct 2026
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
Nature Metabolism · 2 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026